Logo
x

Search

Subscribe Now

Anca-Associated Vasculitis

OncoOne Entered into an Agreement with GenScript ProBio for the Manufacturing of Monoclonal Antibody Therapies Targeting oxMIF

OncoOne Entered into an Agreement with GenScript ProBio for the Manufacturing of Monoclonal Antibody Therapies Targeting oxMIF

  • November 18, 2021
ChemoCentryx's Tavneos (avacopan) Receives the US FDA's Approval as an Adjunctive Treatment for Adult Patients with ANCA-Associated Vasculitis

ChemoCentryx's Tavneos (avacopan) Receives the US FDA's Approval as an Adjunctive Treatment for Adult Patients with ANCA-Associate...

  • October 8, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.